AVTR Avantor, Inc. Common Stock
$14,01
Cena · Sie 19, 2026
Dane fundamentalne na dzień Lip 29, 2026
Zakres 52 tyg.
$7–$16
78% of range
Ocena Analityków
HOLD
25 analysts
Cena Docelowa
$15
+4% upside
P/E (TTM)
-18.0
ROE
-8.9%
Marża Zysku Netto
-8.1%
O Avantor, Inc. Common Stock Przegląd firmy z Wikipedii
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.
Czytaj więcej
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.
History
The company's history traces back to 1904, when John Townsend Baker (1860–1935) founded the chemical company J.T. Baker specializing in producing chemically pure reagents. The company gained recognition for its "Baker Analyzed" labels, which provided detailed analyses of trace impurities in its products. In 1911, the company began publishing "The Chemist-Analyst," which promoted its products and philosophy. After Baker's death in 1935, the company was acquired by Vick Chemical Company in 1941. During World War II, J.T. Baker expanded its product line to include penicillin, pesticides, and chemicals for batteries and munitions. After the war, the company further diversified into high-purity solvents, chromatography columns, and hazardous waste spill kits. In 1985, J.T. Baker and its parent company Richardson-Vicks were sold to Procter & Gamble, and subsequently sold to Mallinckrodt in 1995.
In 2010, investment firm New Mountain Capital purchased Mallinckrodt Baker Inc., which then changed its name to Avantor. The company extended its international market with the 2011 acquisitions of the Indian laboratory reagents supplier RFCL and the Polish lab supply firm POCH.
In 2016, Avantor merged with Nusil Technology. In 2017, Avantor acquired chemical blending business Puritan Products Inc. and laboratory supplies company VWR. The combined company operates under the Avantor name, with VWR and vwr.com remaining as a selling channel.
In May 2019, Avantor went public with a $3.8 billion initial public offering, which gave the company a market capitalization of $7.62 billion. As of December 2023, the top shareholders of Avantor included Vanguard Group Inc., Dodge & Cox Inc., T. Rowe Price Investment Management Inc., and BlackRock Inc.
That same year the company expanded further into Asia with the opening of an innovation center in Shanghai, which focuses on monoclonal antibodies and cell and gene therapy. In 2020, Avantor doubled the size of its Bridgewater, New Jersey innovation center, expanding its research and development capabilities and cell and gene therapy reagent manufacturing.
In 2020, Avantor began providing services and raw materials to companies manufacturing vaccines and other therapies to fight the COVID-19 pandemic. Avantor added employees and extra shifts in order to increase capacity for producing synthetic lipids that are formed into nanoparticles, which carry mRNA into human cells.
In June 2021, Avantor acquired China-based RIM Bio, a manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.
Through the acquisition, Avantor gained access to RIM's Changzhou, China facility, marking Avantor's first single-use production plant in the Africa, Middle East, Asia (AMEA) region. The deal is part of a larger expansion of the company's single-use manufacturing footprint with plans to increase its presence by 30%.
The company ranked 485th in 2023 and 506 in 2024 on the Fortune 500, based on its sales records.
Controversies
On August 26, 2020, Bloomberg News implicated Avantor and other companies in the U.S. opioid epidemic. According to Bloomberg, one of their compounds "acetic anhydride", was used illicitly by drug traffickers to convert crude opium into heroin. Bloomberg also found evidence that Avantor's compound was used in cartel drug labs, and that regulations implemented in 2018 didn't stop it from being widely available. In response, Avantor discontinued all sales of acetic anhydride in Mexico and destroyed its existing inventory. In 2021, Texas Senator John Cornyn, who serves on both the Judiciary Committee and the bipartisan Caucus on International Narcotics Control claims that Avantor should have known better, selling acetic anhydride within Mexico's unregulated market. What should have raised eyebrows as well is that it was sold in 18-liter containers, which is inconsistent with the ordinary use of acetic anhydride. Four other Republican senators also deplored Avantor's “apparent longstanding contribution to the opioid epidemic that killed 50,000 of our fellow citizens in 2019.”
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
AVTR Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$14.01
Kapitalizacja Rynkowa
$9.55B
P/E (TTM)
-18.0
EPS (TTM)
$-0.78
Przychody (TTM)
$6.55B
Stopa dywidendy
—
ROE
-8.9%
D/E Dług/Kapitał
0.7
Zakres 52 tyg.
$7 – $16
AVTR Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$6.55B
2017-12-31
→
2025-12-31
EPS
$-0.78
2018-12-31
→
2025-12-31
Wolny przepływ pieniężny
$495M
2019-12-31
→
2025-12-31
Marże
-8.1%
2019-12-31
→
2025-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
AVTR
Mediana porównawcza
P/E (TTM)
-18.0
39.9
P/S (TTM)
1.5
5.6
P/B
1.7
4.1
EV / EBITDA
-53.3
—
Price / FCF (Cena / FCF)
19.3
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
AVTR
Mediana porównawcza
Gross Margin (Marża brutto)
32.6%
46.4%
Operating Margin (Marża Operacyjna)
-3.8%
—
Net Profit Margin (Marża Zysku Netto)
-8.1%
11.7%
ROA
-4.4%
4.7%
ROE
-8.9%
8.5%
ROIC
-3.1%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
AVTR
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
0.7
15.3
Current Ratio (Wskaźnik bieżący)
1.8
1.7
Quick Ratio (Wskaźnik Szybkości)
1.0
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
AVTR
Mediana porównawcza
Revenue YoY (Przychody R/R)
-3.4%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
-4.5%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
0.49%
—
EPS YoY
121.3%
—
Net Income YoY (Zysk Netto R/R)
121.6%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
AVTR
Mediana porównawcza
AVTR Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
TRZYMAJ
25 analityków
- Mocne kupno 3 12,0%
- Kup 5 20,0%
- Trzymaj 16 64,0%
- Sprzedaj 1 4,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
14 analityków · 2026-08-17
Mediana
$14.20
Teraz
$14.01
Niski
$12.00
Wysoki
$19.00
Średni cel
$14.20
+1,4%
Średnia cel
$14.56
+4,0%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.00%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $0.21 | $0.19 | 0.02% |
| 31 marca 2026 | $0.17 | $0.16 | 0.01% |
| 31 grudnia 2025 | $0.22 | $0.22 | -0.00% |
| 30 września 2025 | $0.22 | $0.23 | -0.01% |
| 30 czerwca 2025 | $0.24 | $0.25 | -0.01% |
| 31 marca 2025 | $0.23 | $0.24 | -0.01% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| AVTR | $7.82B | -14.7 | -3.4% | -8.1% | -8.9% | 32.6% |
| RVTY | $10.86B | 46.7 | 3.7% | 8.5% | 3.3% | — |
| TECH | $7.97B | 111.8 | 5.2% | 6.0% | 3.7% | 64.8% |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| RGEN | $9.23B | 190.5 | 16.4% | 6.6% | 2.4% | — |
| BIO | — | — | — | — | — | — |
| BRKR | $7.17B | -314.1 | 2.1% | -0.25% | -0.40% | 45.9% |
| TXG | $2.08B | -46.6 | 5.2% | -6.8% | -5.5% | 69.0% |
| SHC | $5.02B | 65.3 | 5.7% | 6.7% | 14.0% | 55.5% |
| ADPT | $2.50B | -41.6 | 54.8% | -21.5% | -28.2% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B | $6.39B | $6.04B | $5.86B | $1.25B | |
| Cost of Revenue | $4.41B | $4.50B | $4.60B | $4.91B | $4.88B | $4.31B | $4.12B | $4.04B | $815M | |
| Gross Profit | $2.14B | $2.28B | $2.36B | $2.60B | $2.50B | $2.08B | $1.92B | $1.82B | $433M | |
| SG&A Expense | $1.60B | $1.64B | $1.51B | $1.47B | $1.53B | $1.37B | $1.37B | $1.41B | $450M | |
| Operating Income | $-246M | $1.08B | $696M | $1.13B | $972M | $707M | $552M | $414M | $-210M | |
| Interest Expense | · | · | $285M | $266M | $217M | $308M | $440M | $524M | $201M | |
| Interest Income | $42M | $75M | $65M | $16M | $2M | · | · | · | · | |
| Other Non-op | $-21M | $-1M | $6M | $-800.0K | $11M | $10M | $2M | $-4M | $8M | |
| Pretax Income | $-441M | $854M | $410M | $851M | $753M | $62M | $41M | $-114M | $-460M | |
| Income Tax | $89M | $142M | $89M | $165M | $180M | $-54M | $3M | $-27M | $-315M | |
| Net Income | $-530M | $712M | $321M | $686M | $573M | $117M | $38M | $-87M | $-113M | |
| EPS (Basic) | $-0.78 | $1.05 | $0.48 | $1.02 | $0.86 | $0.09 | $-0.84 | $-2.69 | · | |
| EPS (Diluted) | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 | $0.09 | $-0.84 | $-2.69 | · | |
| Shares (Basic) | 680,600,000 | 679,600,000 | 675,600,000 | 650,900,000 | 590,500,000 | 576,300,000 | 401,200,000 | 132,700,000 | · | |
| Shares (Diluted) | 680,600,000 | 681,900,000 | 678,400,000 | 679,400,000 | 599,600,000 | 583,400,000 | 401,200,000 | 132,700,000 | · | |
| EBITDA | $-246M | $1.08B | $696M | $1.13B | $972M | $707M | $552M | · | · |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $365M | $262M | $263M | $373M | $302M | $287M | $187M | $185M | · | |
| Receivables | $1.07B | $1.03B | $1.15B | $1.22B | $1.22B | $1.11B | $989M | $931M | · | |
| Inventory | $818M | $732M | $828M | $914M | $872M | $740M | $711M | $671M | · | |
| Other Current Assets | $193M | $119M | $144M | $153M | $81M | $91M | $135M | $113M | · | |
| Current Assets | $2.45B | $2.15B | $2.38B | $2.66B | $2.48B | $2.23B | $2.02B | $1.90B | · | |
| PP&E (Net) | $767M | $708M | $738M | $727M | $706M | $550M | $557M | $599M | · | |
| PP&E (Gross) | $1.51B | $1.34B | $1.35B | $1.25B | $1.15B | $938M | $865M | $824M | · | |
| Accum. Depreciation | $745M | $630M | $617M | $518M | $445M | $388M | $308M | $226M | · | |
| Goodwill | $4.99B | $5.54B | $5.72B | $5.65B | $5.34B | $2.86B | $2.77B | $2.78B | $2.85B | |
| Intangibles | $3.10B | $3.27B | $3.68B | $4.04B | $5.05B | $3.96B | $4.13B | $4.47B | · | |
| Other Non-current Assets | $396M | $360M | $358M | $294M | $233M | $217M | $205M | $63M | · | |
| Total Assets | $11.79B | $12.11B | $12.97B | $13.46B | $13.90B | $9.91B | $9.77B | $9.91B | · | |
| Accounts Payable | $742M | $663M | $626M | $758M | $755M | $679M | $560M | $557M | · | |
| Current Liabilities | $1.38B | $2.01B | $1.48B | $1.66B | $1.45B | $1.24B | $1.07B | $1.10B | · | |
| Capital Leases | $152M | $143M | $88M | $87M | $79M | · | $107M | · | · | |
| Deferred Tax | $557M | $557M | $613M | $731M | $913M | $724M | $785M | $908M | · | |
| Other Non-current Liabilities | $378M | $358M | $350M | $295M | $358M | $398M | $428M | $318M | · | |
| Total Liabilities | $6.23B | $6.16B | $7.72B | $8.61B | $9.70B | $7.23B | $7.31B | $9.10B | · | |
| Long-term Debt | $3.95B | $4.06B | $5.54B | $6.29B | $7.02B | $4.89B | $5.12B | $6.92B | · | |
| Total Debt | $3.95B | $4.06B | $5.54B | $6.29B | $7.02B | $4.89B | $5.12B | · | · | |
| Retained Earnings | $1.67B | $2.20B | $1.49B | $1.17B | $484M | $-89M | $-204M | $-238M | · | |
| Treasury Stock | $76M | $0 | · | · | · | · | · | · | · | |
| AOCI | $-17M | $-184M | $-69M | $-100M | $-43M | $22M | $-86M | $-66M | $26M | |
| Stockholders' Equity | $5.57B | $5.96B | $5.25B | $4.86B | $4.20B | $2.67B | $2.46B | $-3.05B | $-2.62B | |
| Liabilities + Equity | $11.79B | $12.11B | $12.97B | $13.46B | $13.90B | $9.91B | $9.77B | $9.91B | · | |
| Shares Outstanding | 682,000,000 | 680,800,000 | 676,600,000 | 674,300,000 | 609,700,000 | 580,100,000 | 572,800,000 | 132,800,000 | · |
Przepływy pieniężne 18
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $410M | $406M | $402M | $406M | $379M | $395M | $399M | $405M | $99M | |
| Stock-based Comp | $46M | $47M | $40M | $46M | $51M | $44M | $68M | $18M | $48M | |
| Deferred Tax | $8M | $-47M | $-172M | $-69M | $-18M | $-88M | $-107M | $-104M | $-431M | |
| Amort. of Intangibles | $301M | $300M | $308M | $318M | $291M | $308M | $312M | $321M | $65M | |
| Restructuring | $30M | $83M | $26M | $4M | $5M | $12M | $24M | $81M | $30M | |
| Operating Cash Flow | $624M | $841M | $870M | $844M | $954M | $930M | $354M | $200M | $-168M | |
| CapEx | $129M | $149M | $146M | $133M | $111M | $62M | $52M | $38M | $25M | |
| Investing Cash Flow | $-130M | $439M | $-144M | $-110M | $-4.12B | $-59M | $-42M | $-23M | $-6.68B | |
| Debt Issued | $1.11B | $0 | $0 | $327M | $2.83B | $3.94B | $1M | $36M | $9.25B | |
| Net Debt Issued | $-319M | $-1.34B | $-846M | $-620M | $2.30B | $-423M | $-1.88B | · | · | |
| Stock Issued | · | · | $0 | $0 | $967M | $0 | $4.24B | · | · | |
| Stock Repurchased | $75M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $-75M | · | $0 | $0 | $967M | · | · | · | · | |
| Financing Cash Flow | $-409M | $-1.28B | $-844M | $-649M | $3.22B | $-783M | $-308M | $-170M | $6.96B | |
| Net Change in Cash | $104M | $-23M | $-109M | $70M | $38M | $100M | $2M | $-800.0K | $122M | |
| Taxes Paid | $145M | $248M | $224M | $257M | $145M | $43M | $112M | $66M | $32M | |
| Free Cash Flow | $495M | $692M | $724M | $710M | $842M | $868M | $302M | · | · | |
| Levered FCF | · | · | $501M | $496M | $677M | $292M | $-107M | · | · |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.6% | 33.6% | 33.9% | 34.6% | 33.9% | 32.5% | 31.8% | · | · | |
| Operating Margin | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% | 11.1% | 9.1% | · | · | |
| Net Margin | -8.1% | 10.5% | 4.6% | 9.1% | 7.8% | 1.8% | 0.63% | · | · | |
| Pretax Margin | -6.7% | 12.6% | 5.9% | 11.3% | 10.2% | 0.97% | 0.67% | · | · | |
| EBITDA Margin | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% | 11.1% | 9.1% | · | · | |
| ROA | -4.4% | 5.7% | 2.4% | 5.0% | 4.8% | 1.2% | 0.38% | · | · | |
| ROE | -8.9% | 12.4% | 6.2% | 14.5% | 13.8% | 4.5% | 1.6% | · | · | |
| ROIC | -3.1% | 9.0% | 5.1% | 8.2% | 6.6% | 17.5% | 6.8% | · | · |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.1 | 1.6 | 1.6 | 1.7 | 1.8 | 1.9 | · | · | |
| Quick Ratio | 1.0 | 0.6 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | · | · | |
| Debt / Equity | 0.7 | 0.7 | 1.1 | 1.3 | 1.7 | 1.8 | 2.1 | · | · | |
| LT Debt / Equity | 0.7 | 0.5 | 1.0 | 1.2 | 1.7 | 1.8 | 2.0 | · | · | |
| Interest Coverage | · | · | 2.4 | 4.3 | 4.5 | 2.3 | 1.3 | · | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | · | · | |
| Inventory Turnover | 5.7 | 5.8 | 5.3 | 5.5 | 6.1 | 5.9 | 6.0 | · | · | |
| Receivables Turnover | 6.2 | 6.2 | 5.9 | 6.2 | 6.3 | 6.1 | 6.3 | · | · |
Stopy Wzrostu 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -3.4% | -2.6% | -7.3% | 1.7% | 15.5% | · | · | · | · | |
| Revenue CAGR 3Y | -4.5% | -2.8% | 2.9% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.49% | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 121.3% | -53.5% | 18.8% | 844.4% | · | · | · | · | |
| EPS CAGR 3Y | · | 7.0% | 73.5% | · | · | · | · | · | · | |
| Net Income YoY | · | 121.6% | -53.2% | 19.9% | 391.1% | · | · | · | · | |
| Net Income CAGR 3Y | · | 7.5% | 40.2% | · | · | · | · | · | · |
Wycena (TTM) 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B | $6.39B | $6.04B | · | · | |
| Net Income TTM | $-530M | $712M | $321M | $686M | $573M | $117M | $38M | · | · | |
| Market Cap | $7.82B | $14.34B | $15.45B | $14.22B | $25.69B | $16.33B | $10.40B | · | · | |
| Enterprise Value | $11.40B | $18.14B | $20.72B | $20.14B | $32.41B | $20.94B | $15.33B | · | · | |
| P/E | -14.7 | 20.3 | 48.6 | 20.9 | 49.6 | 312.8 | -21.6 | · | · | |
| P/S | 1.2 | 2.1 | 2.2 | 1.9 | 3.5 | 2.6 | 1.7 | · | · | |
| P/B | 1.4 | 2.4 | 2.9 | 2.9 | 6.1 | 6.1 | 4.2 | · | · | |
| P / Cash Flow | 12.5 | 17.1 | 17.8 | 16.9 | 26.9 | 17.6 | 29.4 | · | · | |
| P / FCF | 15.8 | 20.7 | 21.3 | 20.0 | 30.5 | 18.8 | 34.4 | · | · | |
| EV / EBITDA | -46.3 | 16.7 | 29.8 | 17.8 | 33.3 | 29.6 | 27.8 | · | · | |
| EV / FCF | 23.0 | 26.2 | 28.6 | 28.4 | 38.5 | 24.1 | 50.7 | · | · | |
| EV / Revenue | 1.7 | 2.7 | 3.0 | 2.7 | 4.4 | 3.3 | 2.5 | · | · | |
| Earnings Yield | -6.8% | 4.9% | 2.1% | 4.8% | 2.0% | 0.32% | -4.6% | · | · |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.69B | $1.58B | $1.66B | $1.62B | $1.68B | $1.58B | $1.69B | $1.71B | $1.70B | $1.68B | $1.72B | $1.72B | $1.74B | $1.78B | $1.79B | $1.86B | |
| Cost of Revenue | $1.16B | $1.08B | $1.14B | $1.10B | $1.13B | $1.05B | $1.12B | $1.15B | $1.12B | $1.11B | $1.15B | $1.14B | $1.15B | $1.16B | $1.18B | $1.21B | |
| Gross Profit | $537M | $501M | $524M | $526M | $554M | $535M | $563M | $564M | $582M | $570M | $570M | $579M | $590M | $625M | $614M | $651M | |
| SG&A Expense | $415M | $401M | $392M | $390M | $425M | $388M | $371M | $440M | $406M | $424M | $387M | $368M | $358M | $394M | $363M | $375M | |
| Operating Income | $122M | $100M | $126M | $-649M | $129M | $147M | $638M | $125M | $176M | $146M | $183M | $210M | $72M | $231M | $252M | $276M | |
| Interest Expense | $39M | $43M | · | $44M | $43M | $42M | · | $49M | $61M | $64M | · | $72M | $73M | $74M | · | $67M | |
| Interest Income | $10M | $10M | $11M | $12M | $11M | $8M | $12M | $27M | $18M | $18M | $18M | $17M | $16M | $14M | · | · | |
| Other Non-op | $-600.0K | $-500.0K | $-1M | $4M | $-4M | $-20M | $-5M | $700.0K | $2M | $1M | $2M | $700.0K | $2M | $600.0K | $-6M | $3M | |
| Pretax Income | $81M | $56M | $81M | $-690M | $82M | $86M | $584M | $74M | $115M | $81M | $120M | $136M | $-1M | $156M | $175M | $208M | |
| Income Tax | $43M | $12M | $28M | $22M | $17M | $21M | $84M | $17M | $22M | $20M | $21M | $28M | $6M | $34M | $33M | $41M | |
| Net Income | $38M | $43M | $52M | $-712M | $65M | $64M | $500M | $58M | $93M | $60M | $98M | $108M | $-7M | $122M | $142M | $167M | |
| EPS (Basic) | $0.06 | $0.06 | $0.08 | $-1.04 | $0.09 | $0.09 | $0.74 | $0.08 | $0.14 | $0.09 | $0.15 | $0.16 | $-0.01 | $0.18 | $0.20 | $0.25 | |
| EPS (Diluted) | $0.06 | $0.06 | $0.08 | $-1.04 | $0.09 | $0.09 | $0.73 | $0.08 | $0.14 | $0.09 | $0.14 | $0.16 | $-0.01 | $0.18 | $0.20 | $0.25 | |
| Shares (Basic) | 676,200,000 | 675,700,000 | -1,363,700,000 | 681,700,000 | 681,500,000 | 681,100,000 | -1,358,200,000 | 680,300,000 | 679,400,000 | 678,100,000 | -1,350,400,000 | 676,000,000 | 675,300,000 | 674,700,000 | -1,277,500,000 | 674,100,000 | |
| Shares (Diluted) | 677,200,000 | 676,800,000 | -1,365,300,000 | 681,700,000 | 681,800,000 | 682,400,000 | -1,365,100,000 | 683,000,000 | 682,600,000 | 681,400,000 | -1,353,500,000 | 678,500,000 | 675,300,000 | 678,100,000 | -1,361,400,000 | 679,300,000 | |
| EBITDA | $122M | $100M | · | $-649M | $129M | $147M | · | $125M | $176M | $146M | · | $210M | $72M | $231M | · | $276M |
Bilans 26
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $307M | $279M | $365M | $252M | $449M | $316M | $262M | $285M | $273M | $235M | · | $237M | $236M | $295M | · | $266M | |
| Receivables | $1.14B | $1.10B | $1.07B | $1.08B | $1.15B | $1.10B | $1.03B | $1.09B | $1.13B | $1.13B | · | $1.15B | $1.22B | $1.28B | · | $1.23B | |
| Inventory | $829M | $810M | $818M | $796M | $780M | $750M | $732M | $780M | $796M | $811M | · | $850M | $890M | $904M | · | $905M | |
| Other Current Assets | $188M | $210M | $193M | $132M | $136M | $120M | $119M | $136M | $132M | $146M | · | $147M | $156M | $152M | · | $158M | |
| Current Assets | $2.46B | $2.40B | $2.45B | $2.26B | $2.51B | $2.28B | $2.15B | $2.50B | $2.33B | $2.32B | · | $2.38B | $2.50B | $2.63B | · | $2.56B | |
| PP&E (Net) | $772M | $766M | $767M | $762M | $759M | $736M | $708M | $723M | $754M | $740M | · | $698M | $698M | $736M | · | $698M | |
| PP&E (Gross) | · | · | $1.51B | · | · | · | $1.34B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $787M | $766M | $745M | $724M | $700M | $663M | $630M | $621M | $657M | $635M | · | $580M | $565M | $541M | · | $489M | |
| Goodwill | $4.94B | $4.95B | $4.99B | $4.98B | $5.76B | $5.61B | $5.54B | $5.67B | $5.66B | $5.67B | $5.72B | $5.64B | $5.69B | $5.68B | $5.65B | $5.51B | |
| Intangibles | $2.92B | $3.01B | $3.10B | $3.17B | $3.26B | $3.24B | $3.27B | $3.43B | $3.49B | $3.57B | · | $3.70B | $3.80B | $3.98B | · | $4.01B | |
| Other Non-current Assets | $412M | $442M | $396M | $406M | $391M | $368M | $360M | $420M | $368M | $368M | · | $289M | $277M | $272M | · | $245M | |
| Total Assets | $11.60B | $11.66B | $11.79B | $11.68B | $12.78B | $12.33B | $12.11B | $12.84B | $12.69B | $12.76B | · | $12.80B | $13.06B | $13.40B | · | $13.11B | |
| Accounts Payable | $743M | $736M | $742M | $692M | $709M | $680M | $663M | $674M | $657M | $573M | · | $656M | $687M | $766M | · | $769M | |
| Current Liabilities | $1.38B | $1.37B | $1.38B | $1.52B | $2.58B | $2.03B | $2.01B | $1.63B | $1.46B | $1.44B | · | $1.49B | $1.55B | $1.67B | · | $1.55B | |
| Capital Leases | · | · | $152M | · | · | · | $143M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $540M | $550M | $557M | $548M | $536M | $550M | $557M | $547M | $575M | $601M | · | $649M | $663M | $696M | · | $728M | |
| Other Non-current Liabilities | $383M | $377M | $378M | $403M | $391M | $365M | $358M | $419M | $362M | $361M | · | $271M | $269M | $300M | · | $334M | |
| Total Liabilities | $5.97B | $6.07B | $6.23B | $6.11B | $6.49B | $6.23B | $6.16B | $7.29B | $7.26B | $7.43B | · | $7.70B | $8.05B | $8.40B | · | $8.52B | |
| Long-term Debt | $3.70B | $3.82B | $3.95B | $3.86B | $4.24B | $4.11B | $4.06B | $4.92B | $5.12B | $5.32B | · | $5.63B | $5.88B | $6.06B | · | $6.19B | |
| Total Debt | $3.70B | $3.82B | · | $3.86B | $4.24B | $4.11B | · | $4.92B | $5.12B | $5.32B | · | $5.63B | $5.88B | $6.06B | · | $6.19B | |
| Retained Earnings | $1.75B | $1.72B | $1.67B | $1.62B | $2.33B | $2.27B | $2.20B | $1.70B | $1.64B | $1.55B | · | $1.39B | $1.28B | $1.29B | · | $1.03B | |
| Treasury Stock | $76M | $76M | $76M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| AOCI | $-55M | $-44M | $-17M | $-24M | $-10M | $-118M | $-184M | $-74M | $-107M | $-97M | · | $-111M | $-72M | $-90M | $-100M | $-212M | |
| Stockholders' Equity | $5.63B | $5.59B | $5.57B | $5.57B | $6.29B | $6.10B | $5.96B | $5.55B | $5.43B | $5.34B | $5.25B | $5.10B | $5.01B | $4.99B | $4.86B | $4.59B | |
| Liabilities + Equity | $11.60B | $11.66B | $11.79B | $11.68B | $12.78B | $12.33B | $12.11B | $12.84B | $12.69B | $12.76B | · | $12.80B | $13.06B | $13.40B | · | $13.11B | |
| Shares Outstanding | · | 682,900,000 | 682,000,000 | 681,900,000 | 681,600,000 | 681,500,000 | 680,800,000 | 680,600,000 | 679,600,000 | 679,200,000 | · | 676,300,000 | 675,700,000 | 675,100,000 | · | 674,200,000 |
Przepływy pieniężne 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $106M | $105M | $103M | $104M | $103M | $100M | $101M | $102M | $103M | $100M | $101M | $98M | $103M | $101M | $101M | $101M | |
| Stock-based Comp | $15M | $9M | $11M | $7M | $16M | $12M | $11M | $12M | $11M | $13M | $9M | $10M | $9M | $13M | $10M | $12M | |
| Deferred Tax | $16M | $-10M | $50M | $-12M | $-18M | $-12M | $28M | $-23M | $-35M | $-18M | $-78M | $-29M | $-38M | $-26M | $-7M | $-22M | |
| Restructuring | · | · | $2M | $2M | · | · | $500.0K | $49M | · | · | $8M | $6M | $7M | $5M | $-200.0K | $1M | |
| Operating Cash Flow | $178M | $59M | $153M | $207M | $154M | $109M | $173M | $245M | $281M | $142M | $252M | $231M | $168M | $220M | $206M | $258M | |
| CapEx | $38M | $34M | $36M | $36M | $30M | $28M | $28M | $41M | $46M | $35M | $51M | $38M | $30M | $28M | $34M | $39M | |
| Investing Cash Flow | $-37M | $-33M | $-40M | $-33M | $-29M | $-29M | $558M | $-40M | $-45M | $-34M | $-50M | $-37M | $-29M | $-27M | $-33M | $4M | |
| Debt Issued | · | · | $1.04B | $68M | $0 | $0 | $0 | $-12M | $-29M | $41M | $0 | $0 | $0 | $0 | $82M | $35M | |
| Net Debt Issued | · | $-105M | · | · | · | $-31M | · | · | · | $-169M | · | · | · | $-270M | · | · | |
| Financing Cash Flow | $-112M | $-107M | $700.0K | $-370M | $-7M | $-34M | $-755M | $-199M | $-197M | $-130M | $-184M | $-188M | $-196M | $-275M | $-82M | $-219M | |
| Net Change in Cash | $28M | $-86M | $114M | $-198M | $134M | $54M | $-46M | $14M | $38M | $-28M | $27M | $-100.0K | $-58M | $-78M | $109M | $27M | |
| Taxes Paid | $30M | $10M | $29M | $22M | $77M | $17M | $120M | $42M | $69M | $17M | $29M | $69M | $113M | $14M | $75M | $51M | |
| Free Cash Flow | · | $25M | · | · | · | $81M | · | · | · | $107M | · | · | · | $192M | · | · | |
| Levered FCF | · | $-8M | · | · | · | $50M | · | · | · | $59M | · | · | · | $134M | · | · |
Rentowność 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.7% | 31.7% | · | 32.4% | 32.9% | 33.8% | · | 32.9% | 34.2% | 34.0% | · | 33.6% | 33.8% | 35.1% | · | 35.0% | |
| Operating Margin | 7.2% | 6.3% | · | -40.0% | 7.6% | 9.3% | · | 7.3% | 10.3% | 8.7% | · | 12.2% | 4.1% | 13.0% | · | 14.9% | |
| Net Margin | 2.2% | 2.7% | · | -43.8% | 3.8% | 4.1% | · | 3.4% | 5.5% | 3.6% | · | 6.3% | -0.42% | 6.8% | · | 9.0% | |
| Pretax Margin | 4.8% | 3.5% | · | -42.5% | 4.9% | 5.4% | · | 4.3% | 6.7% | 4.8% | · | 7.9% | -0.07% | 8.8% | · | 11.2% | |
| EBITDA Margin | 7.2% | 6.3% | · | -40.0% | 7.6% | 9.3% | · | 7.3% | 10.3% | 8.7% | · | 12.2% | 4.1% | 13.0% | · | 14.9% | |
| ROA | 0.31% | 0.36% | · | -5.8% | 0.51% | 0.51% | · | 0.45% | 0.72% | 0.46% | · | 0.84% | -0.06% | 0.89% | · | 1.3% | |
| ROE | 0.64% | 0.74% | · | -12.8% | 1.1% | 1.1% | · | 1.1% | 1.8% | 1.2% | · | 2.2% | -0.15% | 2.6% | · | 3.8% | |
| ROIC | 0.61% | 0.83% | · | -7.1% | 0.97% | 1.1% | · | 0.92% | 1.4% | 1.0% | · | 1.6% | 3.7% | 1.6% | · | 2.1% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.8 | · | 1.5 | 1.0 | 1.1 | · | 1.5 | 1.6 | 1.6 | · | 1.6 | 1.6 | 1.6 | · | 1.6 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.9 | 0.6 | 0.7 | · | 0.8 | 1.0 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.5 | 0.5 | · | 0.8 | 0.9 | 0.9 | · | 1.0 | 1.1 | 1.1 | · | 1.3 | |
| Interest Coverage | 3.1 | 2.3 | · | -14.7 | 3.0 | 3.5 | · | 2.6 | 2.9 | 2.3 | · | 2.9 | 1.0 | 3.1 | · | 4.1 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.4 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.5 |
Wycena (TTM) 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.58B | $6.47B | · | $6.60B | $6.68B | $6.68B | · | $6.82B | $6.85B | $6.92B | · | $7.10B | $7.29B | $7.50B | · | $7.55B | |
| Net Income TTM | $-566M | $-539M | · | $-525M | $280M | $276M | · | $320M | $254M | $283M | · | $390M | $469M | $666M | · | $702M | |
| Market Cap | · | $5.35B | · | $8.51B | $9.17B | $11.05B | · | $17.61B | $14.41B | $17.37B | · | $14.26B | $13.88B | $14.27B | · | $13.21B | |
| Enterprise Value | · | $8.89B | · | $12.12B | $12.97B | $14.84B | · | $22.24B | $19.25B | $22.46B | · | $19.65B | $19.53B | $20.04B | · | $19.14B | |
| P/E | -11.9 | -9.8 | · | -16.0 | 33.6 | 40.5 | · | 55.0 | 55.8 | 60.9 | · | 36.3 | 29.3 | 21.4 | · | 18.7 | |
| P/S | · | 0.8 | · | 1.3 | 1.4 | 1.7 | · | 2.6 | 2.1 | 2.5 | · | 2.0 | 1.9 | 1.9 | · | 1.7 | |
| P/B | · | 1.0 | · | 1.5 | 1.5 | 1.8 | · | 3.2 | 2.7 | 3.3 | · | 2.8 | 2.8 | 2.9 | · | 2.9 | |
| P / Cash Flow | · | 91.2 | · | · | · | 101.1 | · | · | · | 122.6 | · | · | · | 65.0 | · | · | |
| P / FCF | · | 212.5 | · | · | · | 135.9 | · | · | · | 162.5 | · | · | · | 74.5 | · | · | |
| EV / EBITDA | · | 89.4 | · | -18.7 | 100.7 | 100.7 | · | 178.5 | 109.5 | 153.5 | · | 93.5 | 272.3 | 86.7 | · | 69.4 | |
| EV / FCF | · | 352.8 | · | · | · | 182.5 | · | · | · | 210.1 | · | · | · | 104.6 | · | · | |
| EV / Revenue | · | 1.4 | · | 1.8 | 1.9 | 2.2 | · | 3.3 | 2.8 | 3.2 | · | 2.8 | 2.7 | 2.7 | · | 2.5 | |
| Earnings Yield | -8.4% | -10.2% | · | -6.2% | 3.0% | 2.5% | · | 1.8% | 1.8% | 1.6% | · | 2.8% | 3.4% | 4.7% | · | 5.4% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B |
| Marża Brutto % | 32.6% | 33.6% | 33.9% | 34.6% | 33.9% |
| Marża Operacyjna % | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% |
| Zysk netto | $-530M | $712M | $321M | $686M | $573M |
| Rozwodniony EPS | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.7 | 0.7 | 1.1 | 1.3 | 1.7 |
| Wskaźnik bieżący | 1.8 | 1.1 | 1.6 | 1.6 | 1.7 |
| Wskaźnik Szybkości | 1.0 | 0.6 | 1.0 | 1.0 | 1.1 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $495M | $692M | $724M | $710M | $842M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 498 emitentów · $4.9B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 103 (+5 vs poprzedni kw.) | 60 (-10 vs poprzedni kw.) | 175 (+12 vs poprzedni kw.) | 116 (-7 vs poprzedni kw.) | +48.5M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Dodge & Cox | $1 188 207 643 | 120 020 974 | 24,36% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $310 298 175 | 31 343 250 | 6,36% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $304 948 067 | 30 802 835 | 6,25% | Akcje |
| GREENHAVEN ASSOCIATES INC | $243 909 369 | 24 637 310 | 5,00% | Akcje |
| STATE STREET CORP | $213 572 443 | 21 572 974 | 4,38% | Akcje |
| Engine Capital Management, LP | $196 622 217 | 19 860 830 | 4,03% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $189 795 850 | 19 171 298 | 3,89% | Akcje |
| New Mountain Capital, L.L.C. | $138 600 000 | 14 000 000 | 2,84% | Akcje |
| EARNEST PARTNERS LLC | $106 410 397 | 10 748 525 | 2,18% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $103 863 453 | 10 488 055 | 2,13% | Akcje |
| LONDON CO OF VIRGINIA | $103 811 008 | 10 485 960 | 2,13% | Akcje |
| FULLER & THALER ASSET MANAGEMENT, INC. | $101 537 816 | 10 256 345 | 2,08% | Akcje |
| First Pacific Advisors, LP | $81 088 326 | 8 190 740 | 1,66% | Akcje |
| Clarkston Capital Partners, LLC | $67 214 209 | 6 789 314 | 1,38% | Akcje |
| NORGES BANK | $60 307 949 | 6 091 712 | 1,24% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $57 627 841 | 5 820 994 | 1,18% | Akcje |
| Freestone Grove Partners LP | $56 577 352 | 5 714 884 | 1,16% | Akcje |
| GENDELL JEFFREY L | $56 484 183 | 5 705 473 | 1,16% | Akcje |
| FMR LLC | $47 803 595 | 4 828 646 | 0,98% | Akcje |
| YACKTMAN ASSET MANAGEMENT LP | $47 223 000 | 4 770 000 | 0,97% | Akcje |
| AMERIPRISE FINANCIAL INC | $45 927 072 | 4 639 098 | 0,94% | Akcje |
| Brickwood Asset Management LLP | $45 515 438 | 4 597 519 | 0,93% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $42 790 226 | 4 322 245 | 0,88% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $42 363 006 | 4 120 915 | 0,87% | Akcje |
| ROYCE & ASSOCIATES LP | $36 393 232 | 3 676 084 | 0,75% | Akcje |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $34 719 001 | 3 506 970 | 0,71% | Akcje |
| D. E. Shaw & Co., Inc. | $34 716 300 | 3 506 697 | 0,71% | Akcje |
| GOLDMAN SACHS GROUP INC | $32 172 515 | 3 249 749 | 0,66% | Akcje |
| PRIVATE MANAGEMENT GROUP INC | $30 662 617 | 3 097 234 | 0,63% | Akcje |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | $27 663 026 | 2 794 245 | 0,57% | Akcje |
| MARSHALL WACE, LLP | $27 561 641 | 2 784 004 | 0,57% | Akcje |
| Voss Capital, LP | $26 235 000 | 2 650 000 | 0,54% | Akcje |
| Prescott General Partners LLC | $25 740 000 | 2 600 000 | 0,53% | Akcje |
| Gotham Asset Management, LLC | $24 912 796 | 2 516 444 | 0,51% | Akcje |
| Quantinno Capital Management LP | $24 177 175 | 2 442 138 | 0,50% | Akcje |
| KINNEY ASSET MANAGEMENT, LLC | $23 025 600 | 1 845 000 | 0,47% | Akcje |
| Loews Corp | $21 780 000 | 2 200 000 | 0,45% | Akcje |
| Western Standard LLC | $20 888 842 | 2 109 984 | 0,43% | Akcje |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | $18 423 445 | 1 860 954 | 0,38% | Akcje |
| Corient Private Wealth LP | $17 057 534 | 1 722 983 | 0,35% | Akcje |
| SHAPIRO CAPITAL MANAGEMENT LLC | $16 556 859 | 1 672 410 | 0,34% | Akcje |
| RHUMBLINE ADVISERS | $16 514 388 | 1 668 123 | 0,34% | Akcje |
| NEW SOUTH CAPITAL MANAGEMENT INC | $14 578 908 | 1 472 617 | 0,30% | Akcje |
| Robeco Schweiz AG | $14 511 381 | 1 465 796 | 0,30% | Akcje |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $13 775 147 | 1 391 429 | 0,28% | Akcje |
| MACKENZIE FINANCIAL CORP | $13 735 943 | 1 387 469 | 0,28% | Akcje |
| BlackRock, Inc. | $13 157 704 | 1 329 061 | 0,27% | Akcje |
| Swiss National Bank | $13 095 720 | 1 322 800 | 0,27% | Akcje |
| LOOMIS SAYLES & CO L P | $12 659 556 | 1 278 743 | 0,26% | Akcje |
| Clearline Capital LP | $11 125 679 | 1 123 806 | 0,23% | Akcje |
| Lightrock Netherlands B.V. | $10 814 423 | 322 626 | 0,22% | Akcje |
| BANK OF AMERICA CORP /DE/ | $10 782 744 | 1 089 166 | 0,22% | Akcje |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $10 359 261 | 1 046 390 | 0,21% | Akcje |
| Squarepoint Ops LLC | $9 963 815 | 1 006 446 | 0,20% | Akcje |
| Man Group plc | $9 805 722 | 990 477 | 0,20% | Akcje |
| California Public Employees Retirement System | $9 448 907 | 954 435 | 0,19% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $9 444 283 | 953 968 | 0,19% | Akcje |
| SECTOR GAMMA AS | $8 970 271 | 906 088 | 0,18% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $8 342 136 | 842 640 | 0,17% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $8 054 125 | 813 548 | 0,17% | Akcje |
| BARCLAYS PLC | $8 036 592 | 811 777 | 0,16% | Akcje |
| KING LUTHER CAPITAL MANAGEMENT CORP | $7 498 715 | 757 446 | 0,15% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $7 460 392 | 753 575 | 0,15% | Akcje |
| CastleKnight Management LP | $7 441 830 | 751 700 | 0,15% | Akcje |
| Retirement Systems of Alabama | $6 991 024 | 706 164 | 0,14% | Akcje |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $6 974 679 | 704 513 | 0,14% | Akcje |
| EASTERLY INVESTMENT PARTNERS LLC | $6 839 346 | 690 843 | 0,14% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $6 665 215 | 673 254 | 0,14% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $6 598 481 | 841 643 | 0,14% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $6 340 813 | 640 486 | 0,13% | Akcje |
| Melqart Asset Management (UK) Ltd | $6 294 420 | 635 800 | 0,13% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $6 160 664 | 785 799 | 0,13% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $6 057 681 | 611 887 | 0,12% | Akcje |
| Taikang Asset Management (Hong Kong) Co Ltd | $5 791 579 | 585 008 | 0,12% | Akcje |
| COMMONWEALTH EQUITY SERVICES, LLC | $5 790 930 | 584 942 | 0,12% | Akcje |
| ALGERT GLOBAL LLC | $5 706 261 | 576 390 | 0,12% | Akcje |
| FIFTH THIRD BANCORP | $5 584 904 | 564 132 | 0,11% | Akcje |
| Assenagon Asset Management S.A. | $5 513 023 | 556 871 | 0,11% | Akcje |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $5 419 062 | 547 380 | 0,11% | Akcje |
| Vanguard Global Advisers, LLC | $5 363 127 | 541 730 | 0,11% | Akcje |
| Cubist Systematic Strategies, LLC | $5 282 167 | 423 251 | 0,11% | Akcje |
| Amundi | $5 103 480 | 515 503 | 0,10% | Akcje |
| Advisors Capital Management, LLC | $4 369 042 | 441 317 | 0,09% | Akcje |
| Legal & General Group Plc | $4 171 741 | 421 388 | 0,09% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $4 170 177 | 421 230 | 0,09% | Akcje |
| AGMAN CAPITAL LLC | $4 107 490 | 414 898 | 0,08% | Akcje |
| CITADEL ADVISORS LLC | $3 951 555 | 399 147 | 0,08% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $3 663 030 | 370 003 | 0,08% | Akcje |
| State of Tennessee, Department of Treasury | $3 472 841 | 350 792 | 0,07% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $3 426 647 | 346 126 | 0,07% | Akcje |
| Mesirow Institutional Investment Management, Inc. | $3 324 762 | 157 796 | 0,07% | Akcje |
| MetLife Investment Management, LLC | $3 250 566 | 328 340 | 0,07% | Akcje |
| XTX Topco Ltd | $3 202 858 | 323 521 | 0,07% | Akcje |
| NORTHERN TRUST CORP | $3 139 943 | 317 166 | 0,06% | Akcje |
| SOUTHEASTERN ASSET MANAGEMENT INC/TN/ | $3 114 896 | 314 636 | 0,06% | Akcje |
| VANGUARD GROUP INC | $3 114 312 | 271 755 | 0,06% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $2 998 037 | 302 832 | 0,06% | Akcje |
| Bridgewater Associates, LP | $2 982 068 | 301 219 | 0,06% | Akcje |
| Capricorn Fund Managers Ltd | $2 976 930 | 300 700 | 0,06% | Akcje |
| Mariner, LLC | $2 969 786 | 299 976 | 0,06% | Akcje |
Insiderzy spółki 22 insiderów · 16 dyrektorzy generalni · 7 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Michael Stubblefield | President and CEO | 21 maja 2019 A | 1 034 150 | 0 | 0 | $0 |
| Thomas A Szlosek | EVP and CFO | 21 maja 2019 A | 185 714 | 0 | 0 | $0 |
| Corey Walker | President, VWR Dist. & Servs. | 21 czerwca 2026 F | 384 535 | 0 | 0 | $0 |
| Bjorn Hofman | EVP and COO | 21 maja 2019 A | 157 143 | 0 | 0 | $0 |
| Brittany Hankamer | EVP, Chief HR Officer | 14 sierpnia 2026 F | 248 864 | 0 | 0 | $0 |
| Steven W Eck | SVP & Chief Accounting Officer | 31 lipca 2026 F | 129 593 | 0 | 0 | $0 |
| Claudius Sokenu | EVP, Chief Legal & Compliance | 24 lipca 2026 F | 251 228 | 0 | 0 | $0 |
| Frederic Vanderhaegen | EVP, Europe | 21 maja 2019 A | 157 143 | 0 | 0 | $0 |
| Devashish Ohri | EVP, AMEA | 21 maja 2019 A | 157 143 | 0 | 0 | $0 |
| Justin Miller | EVP, Gen. Counsel & Secretary | 21 maja 2019 A | 128 571 | 0 | 0 | $0 |
| Eric Mcallister | EVP and Chief Human Resources Officer | 21 maja 2019 A | 199 051 | 0 | 0 | $0 |
| Ashish Kulkarni | EVP and Chief Technology Officer | 21 maja 2019 A | 128 571 | 0 | 0 | $0 |
| Gerard Brophy | EVP, Biopharma Production | 21 maja 2019 A | 157 143 | 0 | 0 | $0 |
| James Bramwell | EVP, Strategic Partners | 21 maja 2019 A | 128 571 | 0 | 0 | $0 |
| Michael Wondrasch | EVP & CIO | 21 maja 2019 A | 128 571 | 0 | 0 | $0 |
| Christophe Couturier | EVP, Services, Strategy & Business Transformation | 21 maja 2019 A | 157 143 | 0 | 0 | $0 |
| Jo Natauri | Dyrektor | 12 lipca 2021 P | 557 656 | 0 | 0 | $0 |
| Thomas Connolly | Dyrektor | 18 czerwca 2020 S | 72 620 082 | 0 | 0 | $0 |
| Christi Shaw | Dyrektor | 21 maja 2019 A | 14 286 | 0 | 0 | $0 |
| Jonathan M Peacock | Dyrektor | 21 maja 2019 M | 142 001 | 0 | 0 | $0 |
| Rakesh Sachdev | Dyrektor | 21 maja 2019 A | 14 286 | 0 | 0 | $0 |
| Rajiv Gupta | Dyrektor | 21 maja 2019 M | 843 791 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| The Goldman Sachs Group, Inc., Goldman Sachs & Co. LLC, Broad Street Principal Investments, L.L.C., Bridge Street Opportunity Advisors, L.L.C., StoneBridge 2017, L.P., StoneBridge 2017 Offshore, L.P., StoneBridge 2018, L.P., StoneBridge 2018 Offshore, L.P., VWR Partners, L.P. ×8 zgłoszenia | 7 maja 2021 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 75 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| BSJS · Invesco Exchange-Traded Self-Indexe… | 1,42% | 10 581 000 | 8 sierpnia 2026 | Dziennie |
| EPSB · Harbor ETF Trust | 0,57% | 3 303 NS | 30 kwietnia 2026 | N-PORT |
| IJJ · iShares Trust | 0,51% | 3 472 918 SH | 8 sierpnia 2026 | Dziennie |
| IVOV · VANGUARD ADMIRAL FUNDS | 0,39% | 586 296 SH | 8 sierpnia 2026 | Dziennie |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,36% | 360 297 SH | 8 sierpnia 2026 | Dziennie |
| XJH · iShares Trust | 0,28% | 92 514 SH | 8 sierpnia 2026 | Dziennie |
| VFVA · VANGUARD WELLINGTON FUND | 0,27% | 233 604 SH | 8 sierpnia 2026 | Dziennie |
| ISCV · iShares Trust | 0,27% | 143 470 SH | 8 sierpnia 2026 | Dziennie |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,26% | 85 711 SH | 8 sierpnia 2026 | Dziennie |
| MIDE · DBX ETF Trust | 0,25% | 919 NS | 29 maja 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,25% | 2 311 704 NS | 30 kwietnia 2026 | N-PORT |
| IJH · iShares Trust | 0,25% | 23 557 554 SH | 8 sierpnia 2026 | Dziennie |
| IQSM · New York Life Investments ETF Trust | 0,22% | 86 237 NS | 30 kwietnia 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,19% | 1 104 592 SH | 8 sierpnia 2026 | Dziennie |
| ESML · iShares Trust | 0,17% | 375 610 SH | 8 sierpnia 2026 | Dziennie |
| PTMC · Pacer Funds Trust | 0,16% | 78 367 NS | 30 kwietnia 2026 | N-PORT |
| IYH · iShares Trust | 0,14% | 395 710 SH | 8 sierpnia 2026 | Dziennie |
| VBR · VANGUARD INDEX FUNDS | 0,14% | 9 920 672 SH | 8 sierpnia 2026 | Dziennie |
| MVV · ProShares Trust | 0,13% | 23 570 NS | 31 maja 2026 | N-PORT |
| ISCB · iShares Trust | 0,13% | 29 223 SH | 8 sierpnia 2026 | Dziennie |
| BKMC · BNY Mellon ETF Trust | 0,13% | 98 467 NS | 30 kwietnia 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,13% | 78 570 SH | 8 sierpnia 2026 | Dziennie |
| NUSC · Nushares ETF Trust | 0,12% | 191 963 NS | 30 kwietnia 2026 | N-PORT |
| SMMD · iShares Trust | 0,12% | 330 643 SH | 8 sierpnia 2026 | Dziennie |
| SCHM · SCHWAB STRATEGIC TRUST | 0,12% | 1 846 654 NS | 31 maja 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,11% | 11 295 NS | 30 kwietnia 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 274 096 NS | 30 kwietnia 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,10% | 1 983 361 SH | 8 sierpnia 2026 | Dziennie |
| UMDD · ProShares Trust | 0,09% | 3 291 NS | 31 maja 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,09% | 316 237 NS | 30 kwietnia 2026 | N-PORT |
| IWS · iShares Trust | 0,08% | 990 604 SH | 8 sierpnia 2026 | Dziennie |
| REVS · Columbia ETF Trust I | 0,08% | 28 893 NS | 30 kwietnia 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,08% | 1 382 792 NS | 30 kwietnia 2026 | N-PORT |
| WSML · iShares Trust | 0,08% | 41 226 SH | 8 sierpnia 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,08% | 7 835 858 SH | 8 sierpnia 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,08% | 15 636 784 SH | 8 sierpnia 2026 | Dziennie |
| SMDX · Tidal Trust III | 0,08% | 11 859 NS | 30 kwietnia 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,06% | 1 114 744 NS | 30 kwietnia 2026 | N-PORT |
| IWR · iShares Trust | 0,06% | 2 687 402 SH | 8 sierpnia 2026 | Dziennie |
| TILT · FlexShares Trust | 0,05% | 136 752 NS | 30 kwietnia 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 36 298 SH | 8 sierpnia 2026 | Dziennie |
| RECS · Columbia ETF Trust I | 0,04% | 290 577 NS | 30 kwietnia 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 241 833 SH | 8 sierpnia 2026 | Dziennie |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,03% | 26 060 NS | 31 maja 2026 | N-PORT |
| IUSV · iShares Trust | 0,03% | 590 858 SH | 8 sierpnia 2026 | Dziennie |
| FNDX · SCHWAB STRATEGIC TRUST | 0,03% | 701 903 NS | 31 maja 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,02% | 33 794 NS | 31 maja 2026 | N-PORT |
| IWD · iShares Trust | 0,02% | 1 460 870 SH | 8 sierpnia 2026 | Dziennie |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 397 791 SH | 8 sierpnia 2026 | Dziennie |
| SCHV · SCHWAB STRATEGIC TRUST | 0,02% | 341 367 NS | 31 maja 2026 | N-PORT |